• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳糜泻患者的自身抗体不足以阻断组织转谷氨酰胺酶的活性。

Autoantibodies of patients with coeliac disease are insufficient to block tissue transglutaminase activity.

作者信息

Dieterich W, Trapp D, Esslinger B, Leidenberger M, Piper J, Hahn E, Schuppan D

机构信息

Department of Medicine I, University of Erlangen-Nuernberg, Germany.

出版信息

Gut. 2003 Nov;52(11):1562-6. doi: 10.1136/gut.52.11.1562.

DOI:10.1136/gut.52.11.1562
PMID:14570723
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1773855/
Abstract

BACKGROUND AND AIMS

Coeliac disease (CD) is characterised by the presence of autoantibodies against tissue transglutaminase (tTG), the endomysial autoantigen. This study was performed to determine the effect of purified autoantibodies on the enzymatic activity of tTG.

METHODS

Total IgA and IgG class antibodies and purified anti-tTG autoantibodies were isolated from sera of untreated patients with CD and controls. The inhibitory capacity of the antibodies on tTG activity was checked by a fluorometric assay based on the incorporation of monodansyl cadaverine into casein and by tTG-catalysed cross linking of biotinylated cadaverine to gliadin.

RESULTS

The enriched IgA and IgG fractions of five patients with CD and three controls resulted in no significantly different inhibition of enzymatic activity. In contrast, the use of affinity purified anti-tTG autoantibodies of 12 patients with CD led to a dose dependent reduction of tTG activity, compared to control immunoglobulins (n=6). However, the remaining activity was sufficient for cross linking of cadaverine into gliadin, and enzymatic tTG activity was only blocked completely by high concentrations of a monoclonal antibody, which is directed to the active centre of tTG.

CONCLUSIONS

Despite a partial inhibitory effect of isolated anti-tTG autoantibodies from patients with CD, residual enzymatic activity remains sufficiently high to cast doubt on their in vivo relevance.

摘要

背景与目的

乳糜泻(CD)的特征是存在针对组织转谷氨酰胺酶(tTG)(一种肌内膜自身抗原)的自身抗体。本研究旨在确定纯化的自身抗体对tTG酶活性的影响。

方法

从未经治疗的CD患者和对照者的血清中分离出总IgA和IgG类抗体以及纯化的抗tTG自身抗体。通过基于单丹磺酰尸胺掺入酪蛋白的荧光测定法以及tTG催化的生物素化尸胺与麦醇溶蛋白的交联来检测抗体对tTG活性的抑制能力。

结果

5例CD患者和3例对照者的富集IgA和IgG组分对酶活性的抑制无显著差异。相比之下,与对照免疫球蛋白(n = 6)相比,使用12例CD患者的亲和纯化抗tTG自身抗体导致tTG活性呈剂量依赖性降低。然而,剩余的活性足以使尸胺与麦醇溶蛋白交联,并且只有高浓度的针对tTG活性中心的单克隆抗体才能完全阻断tTG的酶活性。

结论

尽管从CD患者中分离出的抗tTG自身抗体有部分抑制作用,但残留的酶活性仍然足够高,使其体内相关性受到质疑。

相似文献

1
Autoantibodies of patients with coeliac disease are insufficient to block tissue transglutaminase activity.乳糜泻患者的自身抗体不足以阻断组织转谷氨酰胺酶的活性。
Gut. 2003 Nov;52(11):1562-6. doi: 10.1136/gut.52.11.1562.
2
Cross linking to tissue transglutaminase and collagen favours gliadin toxicity in coeliac disease.与组织转谷氨酰胺酶和胶原蛋白交联有利于乳糜泻中麦醇溶蛋白的毒性作用。
Gut. 2006 Apr;55(4):478-84. doi: 10.1136/gut.2005.069385. Epub 2005 Sep 27.
3
Anti-tissue transglutaminase antibodies from coeliac patients inhibit transglutaminase activity both in vitro and in situ.来自乳糜泻患者的抗组织转谷氨酰胺酶抗体在体外和原位均能抑制转谷氨酰胺酶的活性。
Gut. 2002 Aug;51(2):177-81. doi: 10.1136/gut.51.2.177.
4
Biochemical and immuno-pathological aspects of tissue transglutaminase in coeliac disease.乳糜泻中组织转谷氨酰胺酶的生化和免疫病理方面
Autoimmunity. 2003 Jun;36(4):221-6. doi: 10.1080/0891693031000118974.
5
Transglutaminase and coeliac disease: endomysial reactivity and small bowel expression.转谷氨酰胺酶与乳糜泻:肌内膜反应性和小肠表达
Clin Exp Immunol. 1999 Dec;118(3):371-5. doi: 10.1046/j.1365-2249.1999.01054.x.
6
Gliadin and tissue transglutaminase complexes in normal and coeliac duodenal mucosa.正常及乳糜泻十二指肠黏膜中的麦醇溶蛋白与组织转谷氨酰胺酶复合物
Clin Exp Immunol. 2003 Dec;134(3):516-24. doi: 10.1111/j.1365-2249.2003.02326.x.
7
Antibody responses to deamidated gliadin peptide show high specificity and parallel antibodies to tissue transglutaminase in developing coeliac disease.对脱酰胺麦醇溶蛋白肽的抗体反应在乳糜泻发展过程中显示出高特异性,并与抗组织转谷氨酰胺酶抗体平行。
Clin Exp Immunol. 2007 Nov;150(2):285-93. doi: 10.1111/j.1365-2249.2007.03487.x. Epub 2007 Sep 4.
8
Evidence for existence of coeliac disease autoantigens apart from tissue transglutaminase.除组织转谷氨酰胺酶外,乳糜泻自身抗原存在的证据。
Eur J Gastroenterol Hepatol. 2000 Sep;12(9):1017-20. doi: 10.1097/00042737-200012090-00009.
9
Elevation of IgG antibodies against tissue transglutaminase as a diagnostic tool for coeliac disease in selective IgA deficiency.抗组织转谷氨酰胺酶IgG抗体升高作为选择性IgA缺乏症中乳糜泻诊断工具的研究
Gut. 2003 Nov;52(11):1567-71. doi: 10.1136/gut.52.11.1567.
10
[Relevance of anti-tissue transglutaminase antibodies in coeliac disease diagnosis].[抗组织转谷氨酰胺酶抗体在乳糜泻诊断中的相关性]
Ann Biol Clin (Paris). 2003 May-Jun;61(3):337-43.

引用本文的文献

1
Intestinal celiac disease - related autoantibodies.肠型乳糜泻相关自身抗体。
Front Immunol. 2025 Jun 6;16:1567416. doi: 10.3389/fimmu.2025.1567416. eCollection 2025.
2
Intestinal Anti-tissue Transglutaminase2 Autoantibodies: Pathogenic and Clinical Implications for Celiac Disease.肠道抗组织转谷氨酰胺酶2自身抗体:对乳糜泻的致病及临床意义
Front Nutr. 2020 May 29;7:73. doi: 10.3389/fnut.2020.00073. eCollection 2020.
3
Interplay between Type 2 Transglutaminase (TG2), Gliadin Peptide 31-43 and Anti-TG2 Antibodies in Celiac Disease.2 型转谷氨酰胺酶(TG2)、麦胶蛋白肽 31-43 与乳糜泻中抗 TG2 抗体的相互作用。
Int J Mol Sci. 2020 May 23;21(10):3673. doi: 10.3390/ijms21103673.
4
Anti-type 2 transglutaminase antibodies as modulators of type 2 transglutaminase functions: a possible pathological role in celiac disease.抗 2 型转谷氨酰胺酶抗体作为 2 型转谷氨酰胺酶功能的调节剂:在乳糜泻中的可能病理作用。
Cell Mol Life Sci. 2018 Nov;75(22):4107-4124. doi: 10.1007/s00018-018-2902-0. Epub 2018 Aug 22.
5
Epitope-dependent Functional Effects of Celiac Disease Autoantibodies on Transglutaminase 2.乳糜泻自身抗体对转谷氨酰胺酶2的表位依赖性功能效应
J Biol Chem. 2016 Dec 2;291(49):25542-25552. doi: 10.1074/jbc.M116.738161. Epub 2016 Oct 26.
6
Transglutaminase 2 and Transglutaminase 2 Autoantibodies in Celiac Disease: a Review.麸质酶 2 和麸质酶 2 自身抗体在乳糜泻中的研究进展。
Clin Rev Allergy Immunol. 2019 Aug;57(1):23-38. doi: 10.1007/s12016-016-8557-4.
7
Effect of Rothia mucilaginosa enzymes on gliadin (gluten) structure, deamidation, and immunogenic epitopes relevant to celiac disease.罗伊氏乳杆菌酶对麦醇溶蛋白(面筋)结构、脱酰胺和与乳糜泻相关的免疫原性表位的影响。
Am J Physiol Gastrointest Liver Physiol. 2014 Oct 15;307(8):G769-76. doi: 10.1152/ajpgi.00144.2014. Epub 2014 Aug 21.
8
Thioredoxin is involved in endothelial cell extracellular transglutaminase 2 activation mediated by celiac disease patient IgA.硫氧还蛋白参与了乳糜泻患者 IgA 介导的内皮细胞细胞外转谷氨酰胺酶 2 的激活。
PLoS One. 2013 Oct 9;8(10):e77277. doi: 10.1371/journal.pone.0077277. eCollection 2013.
9
Pathophysiology of celiac disease.乳糜泻的病理生理学
Gastrointest Endosc Clin N Am. 2012 Oct;22(4):639-60. doi: 10.1016/j.giec.2012.07.003. Epub 2012 Aug 30.
10
The intestinal B-cell response in celiac disease.乳糜泻中的肠道 B 细胞反应。
Front Immunol. 2012 Oct 4;3:313. doi: 10.3389/fimmu.2012.00313. eCollection 2012.

本文引用的文献

1
Transforming growth factor-beta (TGF-beta) and tissue transglutaminase expression in the small intestine in children with coeliac disease.乳糜泻患儿小肠中转化生长因子-β(TGF-β)与组织转谷氨酰胺酶的表达
Scand J Immunol. 2002 Nov;56(5):530-7. doi: 10.1046/j.1365-3083.2002.01157.x.
2
Structural basis for gluten intolerance in celiac sprue.乳糜泻中麸质不耐受的结构基础。
Science. 2002 Sep 27;297(5590):2275-9. doi: 10.1126/science.1074129.
3
Biomedicine. Gluten and the gut-lessons for immune regulation.生物医学。麸质与肠道——免疫调节的经验教训。
Science. 2002 Sep 27;297(5590):2218-20. doi: 10.1126/science.1077572.
4
Celiac lesion T cells recognize epitopes that cluster in regions of gliadins rich in proline residues.乳糜泻病变T细胞识别的表位聚集在富含脯氨酸残基的麦醇溶蛋白区域。
Gastroenterology. 2002 Sep;123(3):803-9. doi: 10.1053/gast.2002.35381.
5
Antibodies against human tissue transglutaminase and endomysium in diagnosing and monitoring coeliac disease.抗人组织转谷氨酰胺酶和肌内膜抗体在乳糜泻诊断和监测中的应用
Scand J Gastroenterol. 2002 Jun;37(6):685-91. doi: 10.1080/00365520212496.
6
A reliable screening procedure for coeliac disease in clinical practice.临床实践中一种可靠的乳糜泻筛查程序。
Scand J Gastroenterol. 2002 Jun;37(6):679-84. doi: 10.1080/00365520212513.
7
Anti-tissue transglutaminase antibodies from coeliac patients inhibit transglutaminase activity both in vitro and in situ.来自乳糜泻患者的抗组织转谷氨酰胺酶抗体在体外和原位均能抑制转谷氨酰胺酶的活性。
Gut. 2002 Aug;51(2):177-81. doi: 10.1136/gut.51.2.177.
8
Gliadin T cell epitope selection by tissue transglutaminase in celiac disease. Role of enzyme specificity and pH influence on the transamidation versus deamidation process.组织转谷氨酰胺酶在乳糜泻中对麦醇溶蛋白T细胞表位的选择。酶特异性和pH对转酰胺基与脱酰胺基过程的影响。
J Biol Chem. 2002 Sep 13;277(37):34109-16. doi: 10.1074/jbc.M204521200. Epub 2002 Jul 1.
9
The gluten response in children with celiac disease is directed toward multiple gliadin and glutenin peptides.患有乳糜泻的儿童对麸质的反应针对多种麦醇溶蛋白和麦谷蛋白肽段。
Gastroenterology. 2002 Jun;122(7):1729-37. doi: 10.1053/gast.2002.33606.
10
Specificity of tissue transglutaminase explains cereal toxicity in celiac disease.组织转谷氨酰胺酶的特异性解释了乳糜泻中的谷物毒性。
J Exp Med. 2002 Mar 4;195(5):643-9. doi: 10.1084/jem.20012028.